Ambler, PA, United States of America

Aniruddha M Railkar

USPTO Granted Patents = 2 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Aniruddha M Railkar: Innovator in Oral Delivery Systems

Introduction

Aniruddha M Railkar is a notable inventor based in Ambler, Pennsylvania, recognized for his contributions to the field of pharmaceutical formulations. With a total of two patents to his name, Railkar has made significant strides in developing innovative solutions for drug delivery.

Latest Patents

Railkar's latest patents focus on room temperature stable oral calcitonin formulations. These patents disclose room-temperature stable dosage forms for the oral delivery of calcitonin, which are crucial for ensuring the stability and efficacy of the medication. The formulations also include low water content dosage forms, which are essential for maintaining the integrity of the active ingredient. Furthermore, the patents outline methods for producing these stable dosage forms and detail treatment methods that involve the administration of such formulations.

Career Highlights

Throughout his career, Aniruddha M Railkar has worked with prominent companies in the pharmaceutical industry, including Enteris Biopharma, Inc. and Taurus Development Company LLC. His experience in these organizations has contributed to his expertise in drug formulation and delivery systems.

Collaborations

Railkar has collaborated with several professionals in his field, including James P Gilligan and George R Maurer. These collaborations have likely enhanced his research and development efforts, leading to innovative solutions in pharmaceutical formulations.

Conclusion

Aniruddha M Railkar's work in developing room temperature stable oral calcitonin formulations showcases his commitment to advancing pharmaceutical technology. His contributions are significant in improving drug delivery systems, ultimately benefiting patients who rely on these medications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…